Data Bridge
Market Research adds “Global
Hypercalcemia Treatment Market 2017-2024”, By Technology (Bisphosphonates
(Clodronate, Etidronate, Ibandronate, Pamidronate and Zoledronic acid),
Calcitonin, Glucocorticoids, Denosumab, Calcimimetics), By Distribution Channel
(Direct Tenders, Retail), By End User (Hospitals, Clinics), By Geography (North
America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) and
Forecast to 2024
Global
Hypercalcemia Treatment Market accounted to USD 76.9 billion in 2016 growing
at a CAGR of 11.5% during the forecast period of 2017 to 2024.
This report consists of below pages:
·
No of pages: 350
·
No of Figures: 60
·
No of Tables: 220
Get Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-hypercalcemia-treatment-market
Report Definition:
Hypercalcemia is a condition
caused due to high calcium level in the blood which leads to weak bones, kidney
stones and also interferes in the functioning of heart and brain. Hypercalcemia
treatment involves treatment of underlying diseases, restoring extracellular
volume, correcting electrolyte deficiencies (potassium and magnesium), and
reducing bone resorption.
Major
Market Drivers and Restraints:
·
Expanding label indications
·
Increasing hip and knee
replacement procedures will increase the risk of hypercalcemia
·
Increasing surgical procedures
·
Severe threat of damage to
nervous system
Hypercalcemia
Treatment Market Segmentation:
By technology the market for hypercalcemia treatment is segmented into
bisphosphonates, calcitonin, glucocorticoids, denosumab, calcimimetics.
On the basis of distribution
channel the
market is segmented into direct and retail.
On the basis of end-users the hypercalcemia treatment
market is segmented into hospitals and clinics.
On the basis of geography, hypercalcemia treatment market
report covers data points for 28 countries across multiple geographies such as North America & South America, Europe,
Asia-Pacific, and Middle East & Africa. Some of the major countries
covered in this report are U.S., Canada, Germany, France, U.K., Netherlands,
Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia,
Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North
America is expected to dominate the market.
Speak
to Analyst about this Report Visit @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-hypercalcemia-treatment-market
Hypercalcemia
Treatment Market Competitive Analysis:
The
global hypercalcemia treatment market is highly fragmented and is based
on new product launches and clinical results of products. Hence the major
players have used various strategies such as new product launches, clinical
trials, market initiatives, high expense on research and development,
agreements, joint ventures, partnerships, acquisitions, and others to increase
their footprints in this market. The report includes market shares of
hypercalcemia treatment market for global, Europe, North America, Asia Pacific
and South America.
Hypercalcemia
Treatment Market Major Market Competitors:
Some
of the major players operating in hypercalcemia treatment market are:
·
AbbVie
·
Amgen
·
Merck
·
Novartis
and OPKO Health
·
DiaSorin
·
Rockwell
Medical
·
Kyowa
Hakko Kirin
·
Fujirebio
·
Pharma
AG
·
Sun
Pharmaceutical Industries Ltd.
·
Mylan
N.V.
·
Pfizer
Inc.
·
Amgen
Inc.
·
Novartis
AG
·
Dr.
Reddy’s Laboratories Ltd.
·
Cipla
Inc.
·
Bayer
Pharma AG
·
Sun
Pharmaceutical Industries Ltd. among others.
View Full Report Visit @ http://databridgemarketresearch.com/reports/global-hypercalcemia-treatment-market/
Related Report
Global
In Situ Hybridization Market – Industry Trends and Forecast to 2024
Global In Situ
Hybridization Market By Product (Fluorescent In Situ Hybridization, Chromogenic
In Situ Hybridization), By Application (Cell Biology Research, Neuroscience,
Oncology and Others), By End-User (Pharma And Biotechnology Laboratories,
Research And Academics, Hospitals, Others), By Geography (North America,
Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry
Trends and Forecast to 2024
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Vishal
Dixit
Data
Bridge Market Research
Tel:
+1-888-387-2818
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research